The Structural Disease Center

Filter Your Results




United States Pivotal Study Begins for Abbott's Amplatzer Device to Treat Patent Ductus Arteriosus in Newborns

August 30, 2017 -- Abbott Vascular announced that it has initiated a United States pivotal clinical study evaluating the safety and effectiveness of a modified version of its …

IDE Study Begins for BioVentrix's Revivent TC System for Ischemic Cardiomyopathy

August 21, 2017 -- BioVentrix, Inc. announced enrollment of the first patient in the international arm of the ALIVE pivotal clinical trial. The trial is designed to demonstrat…

Postapproval Study Evaluates Amplatzer Septal Occluder for Closure of Secundum ASD

August 14, 2017 -- Findings from a multicenter, prospective postapproval study of percutaneous closure of secundum atrial septal defects (ASDs) with the Amplatzer septal occlu…

Emerging Options for Anticoagulation in LAA Closure

Jessica Tilton, PharmD, BCACP; John Shilka, PharmD; Adhir Shroff, MD, MPH; and Vicki Groo, PharmD

July/August 2017—Managing anticoagulation and antiplatelet therapy in patients undergoing percutaneous left atrial appendage closure with the Watchman device.

First Procedures Performed With Millipede's 50-mm Transcatheter Annuloplasty Ring

July 24, 2017 -- Millipede, Inc. announced the successful implantation of its new 50-mm Iris annuloplasty ring with a transfemoral, transseptal delivery catheter in a patient …

Funding Will Support Development of 4C Medical's Transcatheter Technology for Mitral Regurgitation

July 19, 2017 -- 4C Medical Technologies, Inc., a Minnesota-based company focused on the development of minimally invasive therapies for structural heart disease, announced fu…

An Interview With Saibal Kar, MD

May/June 2017—Dr. Kar shares his insights on current left atrial appendage closure data, as well as his thoughts on transcatheter mitral and tricuspid repair.

The Approval of PFO Closure in the United States

Marie-France Poulin, MD; and Clifford J. Kavinsky, MD, PhD

May/June 2017—A look back at the long road to FDA approval and the implications on patient care options going forward.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.